Organization
Evaluate Technologies Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Evaluate Technologies Ltd.
... " report from EP Vantage, the editorial arm of market intelligence firm Evaluate Ltd. The EP Vantage analysis has identified over 150 PD-1/PD-L1 combinations currently ...
... the "EvaluatePharma Orphan Drug Report 2015" from life science market intelligence firm Evaluate Ltd. "For three years, Evaluate has tracked the trajectory of this specialty ...
... AdvaMed ) and Alexander Karle, CEO of life science market intelligence firm Evaluate Ltd today announced a collaboration to arrange for preferred medtech market intelligence ...
... Preview 2015, Outlook to 2020" report from life science market intelligence firm Evaluate Ltd. The report also found that worldwide medtech R&D expenditure is forecast ...
... Half-Year Review report can be downloaded for free at www.evaluategroup.com/MedtechHalfYear2015 . About Evaluate Ltd. Evaluate is the trusted source for life science market intelligence and ...
... by EP Vantage, editorial arm of the life science market intelligence firm Evaluate Ltd. Gilead Sciences, Celgene and Shire are leading in pharma sales generated ...
... 2015, Outlook to 2020 " report from life science market intelligence firm Evaluate Ltd. With the FDA approving an unprecedented 50 drugs in 2014, eight ...
... Life science market intelligence firm, Evaluate Ltd, is launching their annual complimentary industry report, "EvaluatePharma World Preview 2015, ...
... Life science market intelligence firm, Evaluate Ltd, has partnered with AdverseEvents, Inc. (AEI), a leading healthcare informatics company ...
... report published by EP Vantage, the editorial arm of market intelligence firm Evaluate Ltd. MedTech 2014 in Review Highlights FDA approved devices rose to 33 ...
... report published by EP Vantage, the editorial arm of market intelligence firm Evaluate. Pharma & Biotech 2014 in Review Highlights: Specialty pharma M&A frenzy, including ...
... $34 billion between 2010-2014, up from $16.9 billion during 2005-2009 according to Evaluate's new report " Japan Sales, Volume, Pricing 2015 ." "Japan is the ...
... report published by EP Vantage, the editorial arm of market intelligence firm Evaluate Ltd. "CAR-T therapy looks like it's becoming little short of a revolution ...
... Preview ." EP Vantage is the editorial arm of market intelligence firm Evaluate Ltd. Key findings: A dozen products due to be launched next year ...
... new " EvaluatePharma® Orphan Drug Report 2014 " from market intelligence firm Evaluate Ltd. At 11 percent, growth in the orphan drug market is set ...
... 2013 and 2020, according to the latest forecasts from market intelligence firm Evaluate Ltd. Its new report, " EvaluateMedTech World Preview 2014, Outlook to 2020 ...
... in 2010 to $9,400 in 2014, representing a seven-fold increase, according to Evaluate's new report, " Budget-busters: The Shift to High-Priced Innovator Drugs in the ...
... No. 3, adding 3,000 jobs, according to the study by market-research firm Evaluate Ltd. Little Canada-based. St. Jude ranked No. 5 with 818 hires, bringing ...
... Founder and CEO Receives PharmaVOICE 100 Award Life science market intelligence company, Evaluate, Ltd. , announced today that Founder and CEO, Dr. Jonathan de Pass, ...
... growth prove that the industry is turning a new corner, according to Evaluate's " World Preview 2014, Outlook to 2020 " report. "This much improved ...
... 2020 as EvaluatePharma Extends Consensus Sales Forecasts Life science market intelligence company, Evaluate, Ltd. , announced today that it has extended its exclusive consensus sales ...
... announced the closing of $2 Million in Series A financing led by Evaluate Ltd., a market intelligence leader in consensus forecasts and analysis of the ...
... Year for Unmet Diseases," from EP Vantage , the editorial arm of Evaluate. The FDA data indicate that no fewer than 141 BTDs have been ...
... Products Driving Record Success," from EP Vantage , the editorial arm of Evaluate. While the total tally of approved drugs and biologics for 2013 is ...
... Evaluate Ltd. Launches Innovative Life Sciences Market Assessment Solution for Healthcare Decision Makers ...
Want to see the full history on Evaluate Technologies Ltd.? Upgrade to RelSci Pro now!
Start My Free Trial